Search

close   X

healthcare locations

Search Locations

close   X

Ayman El-Sheikh, MD, Medical Director

expertise

blood and marrow transplants, solid tumor treatment including bone tumors and sarcomas, education research

bio

Dr. Ayman El-Sheikh is the medical director of the hematology/oncology department at Dayton Children’s. He leads a team of pediatric specialists, nurses, social workers, child life specialists and other care professionals who ensure that children battling cancer or blood disorders get the multidisciplinary approach that ensures that their unique medical and psychological needs are met. Dr. El-Sheikh is board certified in pediatrics and pediatric hematology/oncology. He is especially interested in blood and marrow transplants, solid tumor treatment, education and research. Dr. El-Sheikh joined Dayton Children’s in 2015 from the University of Iowa Children’s Hospital in Iowa City, where he was the director of the pediatric blood and marrow transplant program, the institutional principal investigator for the Children’s Oncology Group (COG) and the medical director of the inpatient ward. He was also a clinical assistant professor of pediatric hematology/oncology at Carver College of Medicine at the University of Iowa, as well as on the admissions committee. Along with English, Dr. El-Sheikh also speaks Arabic.

education and training

  • medical school: Tanta University, Egypt
  • internship: UMDNJ Camden NJ
  • residency: Children’s Regional Hospital, Camden, New Jersey - Pediatrics
  • fellowship: Iowa Children’s Hospital, Iowa City- Pediatric hematology/oncology and blood and marrow transplant
  • board certification:
    • Pediatrics
    • Pediatric hematology/oncology

publications and presentations

  • Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension with pigeon chest deformity. El-Sheikh AA, Hashem H, Holman C, Vyas YM.
  • Pediatr Blood Cancer. 2014 Aug;61(8):1460-2. doi: 10.1002/pbc.24945. Epub 2014 Jan 13. PMID: 24420417 Similar articles. Select item 243760493.
  • Neuroblastoma in monozygotic twins with distinct presentation pathology and outcome: is it familial or in utero metastasis. Abu-Arja R, Hashem H, El-Sheikh A, Abusin G.
  • Pediatr Blood Cancer. 2014 Jun;61(6):1124-5. doi: 10.1002/pbc.24906. Epub 2013 Dec 23. Review. PMID: 24376049 Similar articles. Select item 202324244.
  • Inhibition of Aurora Kinase A enhances chemosensitivity of medulloblastoma cell lines. El-Sheikh A, Fan R, Birks D, Donson A, Foreman NK, Vibhakar R. Pediatr Blood Cancer. 2010 Jul 15;55(1):35-41. doi: 10.1002/pbc.22465. PMID: 20232424

awards, honors and organizations

Member of:

  • ASPHO
  • ASH
  • ASCO
  • AAP

get to know me

I chose my specialty because...

it gives me the opportunity to develop lifelong relationships with families and patients.


I chose to work at Dayton Children's because...

it is a great institution to work for and it reflects on my own values of delivering compassionate, family-centered care to all we serve.


Dayton Children's is special because...

the team work environment that enable us to work collaboratively to care for children, their families and each other and because we continuously innovate to make Dayton Children’s even better.


ratings and reviews
star star star star star

Dayton Survey

I have said time and again, I would not choose Dayton Children's Hospital if I could drive a longer distance on a regular basis.

star star star star star

Dayton Survey

None

star star star star star

Dayton Survey

The entire team we met with were professional and knowledgeable. They answered all of our and our daughter's questions. They made the multiple blood draws easy and timely. We appreciated their team approach. We left confident in how to manage our daughter's health condition.

star star star star star

Dayton Survey

That everyone at children's was great with my son and with us, his parents.

Load more testimonials...